文献速递多重用药老年综合评估衰弱、肌少症与跌倒

药师主导的干预措施在PACE项目中减少尿路抗胆碱能药物使用的可行性研究

Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the Elderly.
PubMed 文献 · J Am Geriatr Soc · 2022-07-28

这项回顾性前后对照研究在35个PACE项目中评估药师提出的减少尿路抗胆碱能药物(UAM)使用建议的实施率、抗胆碱能暴露变化及预测因素。187名参与者中建议实施率为63.1%,实施者总体抗胆碱能标准化日剂量(SDD)从基线2.6降至第9个月0.9(降幅65.4%,p<0.001),未实施者无显著变化。基线用药<10种、基线UAM SDD≥2、建议简单及基线使用钙通道阻滞剂可预测实施。

要点

  • 药师减少UAM使用的建议在 medically complex 社区老年人中实施率达63.1%,77.1%在2个月内完成。
  • 实施者总体抗胆碱能SDD从2.6降至0.9(降65.4%,p<0.001),未实施者无显著变化。
  • 基线用药<10种、UAM SDD≥2、建议简单及使用钙通道阻滞剂预测建议实施。

核心结论

  • 药师提出减少UAM使用以降低总体抗胆碱能暴露的建议,在 medically complex、社区居住的老年人中具有可行性,实施率较高。

研究设计与样本

  • 回顾性、观察性、前后对照研究,纳入35个PACE项目的187名参与者(平均年龄72.4±9.4岁,77.0%女性,平均用药数12.9±4.6),由18名药师制定减少UAM策略,PACE处方者决定是否实施。

主要发现

  • 9个月内187名参与者中118名实施了建议,实施率63.1%,其中77.1%(91/118)在第2个月时已实施。
  • 实施者总体抗胆碱能SDD从基线2.6(95%CI 2.2-3.0)降至第9个月0.9(95%CI 0.6-1.2),降幅65.4%,p<0.001;未实施者无显著变化(p=0.52)。
  • 基线用药<10种(OR 2.75;95%CI 1.09-7.61)、基线UAM SDD≥2(OR 2.20;95%CI 1.11-4.44)、建议简单(OR 3.38;95%CI 1.67-7.03)及基线使用钙通道阻滞剂(OR 2.19;95%CI 1.09-4.52)预测建议实施。

临床怎么用

  • 在PACE等社区老年照护项目中,可让药师主导识别并建议减少UAM使用,处方者实施后能显著降低总体抗胆碱能暴露。
  • 优先针对基线用药较少、UAM SDD较高、建议较简单及使用钙通道阻滞剂的患者,可能提高建议实施率。

局限性

  • 本研究为回顾性观察性前后对照设计,未设随机对照,无法排除混杂因素。
  • 研究未评估减少UAM建议对认知(如谵妄、痴呆)或躯体功能(如跌倒)的临床获益,需未来研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given associations with serious cognitive and physical adverse effects (e.g., dementia, falls), strong anticholinergics, like urinary antimuscarinics (UAMs), should be avoided in older adults. This feasibility study aimed to (1) evaluate the implementation rate of pharmacists' recommendations intended to de-escalate UAMs, (2) quantify the change in overall anticholinergic dosing exposure from these recommendations, and (3) investigate factors that predict recommendation implementation. METHODS: This was a retrospective, observational, before-and-after study. Pharmacists (n = 18) devised strategies to de-escalate UAMs in 187 participants (mean age 72.4 ± 9.4; 77.0% female; mean number of medications 12.9 ± 4.6) of 35 Programs of All-Inclusive Care for the Elderly (PACE). PACE prescribers (non-physicians and physicians) determined whether to implement recommendations. Implementation was defined as a change in the prescription records consistent with the pharmacist's recommendation at 2-, 4-, 6-, and 9-months post-recommendation. Anticholinergic dosing exposure was measured at each time point using standardized daily doses (SDD). Multivariable logistic regression was used to identify factors that predicted recommendation implementation. RESULTS: Across 9 months, recommendations were implemented in 118 out of 187 participants, yielding a 63.1% implementation rate. Of these, 77.1% (n = 91/118) implemented by month 2. Implementers' mean overall anticholinergic SDD decreased 65.4% from baseline (baseline: 2.6 [95% CI: 2.2, 3.0] to month 9: 0.9 [95% CI: 0.6,1.2], p < 0.001) whereas non-implementers demonstrated no significant change (p = 0.52). Taking <10 baseline medications (OR 2.75; 95% CI: 1.09, 7.61); baseline UAM SDD ≥2 (OR 2.20; 95% CI: 1.11, 4.44); uncomplicated recommendations (OR 3.38; 95% CI: 1.67-7.03); and baseline calcium channel blocker use (OR 2.19; 95% CI: 1.09, 4.52) predicted implementation. CONCLUSION: Our high implementation rate indicates that pharmacists' recommendations to de-escalate UAMs as a way to reduce overall anticholinergic exposure is feasible in medically complex, community-dwelling older adults. Future research should investigate whether these recommendations benefit cognitive (e.g., delirium, dementia) and/or physical functioning (e.g., falls).

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Ha M, Furman A, Al Rihani SB, et al. Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the Elderly. J Am Geriatr Soc. 2022. PMID: 35900034. doi:10.1111/jgs.17965

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。